You are here

  • Home
  • Archive
  • Volume 12, Issue 5
  • First-dose idarubicin cardiomyopathy: a case of new heart failure after induction chemotherapy for acute myeloid leukaemia

Article info

Article menu
Download PDFPDF
Unexpected outcome (positive or negative) including adverse drug reactions
CASE REPORT
First-dose idarubicin cardiomyopathy: a case of new heart failure after induction chemotherapy for acute myeloid leukaemia

Authors

  1. Correspondence to Dr Zarir Ahmed, zarirmed{at}gmail.com
View Full Text

Citation

Ahmed Z, Davaro E, Batanian J, et al
First-dose idarubicin cardiomyopathy: a case of new heart failure after induction chemotherapy for acute myeloid leukaemia
BMJ Case Reports CP 2019;12:e228149.

Publication history

  • Accepted May 1, 2019
  • First published May 16, 2019.
Online issue publication 
September 27, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.